Earnings Summary

Usana Health Sciences Inc.’s revenue fell -9.93% since last year same period to $238.2Mn in the Q2 2023. On a quarterly growth basis, Usana Health Sciences Inc. has generated -4.09% fall in its revenue since last 3-months.

Usana Health Sciences Inc.’s net profit fell -9.74% since last year same period to $17.29Mn in the Q2 2023. On a quarterly growth basis, Usana Health Sciences Inc. has generated -5.93% fall in its net profits since last 3-months.

Usana Health Sciences Inc.’s net profit margin jumped 0.22% since last year same period to 7.26% in the Q2 2023. On a quarterly growth basis, Usana Health Sciences Inc. has generated -1.92% fall in its net profit margins since last 3-months.

Usana Health Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.35 - a -60.67% fall from last quarter’s estimates.

Usana Health Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 0.35.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Usana Health Sciences Inc.’s return on assets (ROA) stands at 0.1.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Usana Health Sciences Inc.’s return on equity (ROE) stands at 0.15.